Review finds possible short-term symptom relief, but not enough evidence for…
Are Cannabis and Cannabinoids a Valid Treatment Option in Patients with Rheumatic Diseases? A narrative review.
AI Summary
This narrative review asked whether cannabis and cannabinoid therapies are effective and safe for people with rheumatic diseases. It searched for studies published from 2000 to 2026 and identified 17 preclinical studies and 43 clinical studies, including randomized trials, observational studies, and systematic reviews. The abstract does not report pooled effect sizes or other quantitative treatment outcomes.
Evidence of possible benefit was strongest for fibromyalgia and more limited for rheumatoid arthritis and osteoarthritis. Most studies reported improvements in pain and sleep quality, and cannabinoids were generally described as well tolerated. However, findings were inconsistent, and the authors conclude that evidence is insufficient to support routine clinical use or recommendations. As an abstract-based summary, this review cannot establish how much benefit patients may experience; its conclusions are limited by small samples, varied formulations, and risk of bias in the underlying studies.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Pain research papers you might find interesting.
Survey links cannabis use with anxiety and opioid use in bleeding disorders
Mouse study finds tea extract eased G-CSF-related pain, not mobilization
Nanoencapsulated CBD prolonged pain responses in a mouse model
Explore More Research
Stay informed about the latest cannabis science.
